#FORMAT=WebAnno TSV 3.2
#T_SP=webanno.custom.Referent|entity|infstat
#T_RL=webanno.custom.Coref|type|BT_webanno.custom.Referent


#Text=http://www.who.int/csr/disease/swineflu/guidance/national_authorities/en/index.html
1-1	0-83	http://www.who.int/csr/disease/swineflu/guidance/national_authorities/en/index.html	abstract	new	_	_

#Text=What does the WHO recommend for those individuals affected by H1N1 ?
2-1	84-88	What	_	_	_	_
2-2	89-93	does	_	_	_	_
2-3	94-97	the	organization[2]	new[2]	coref	6-1[0_2]
2-4	98-101	WHO	organization[2]	new[2]	_	_
2-5	102-111	recommend	_	_	_	_
2-6	112-115	for	_	_	_	_
2-7	116-121	those	person[3]	new[3]	_	_
2-8	122-133	individuals	person[3]	new[3]	_	_
2-9	134-142	affected	person[3]	new[3]	_	_
2-10	143-145	by	person[3]	new[3]	_	_
2-11	146-150	H1N1	person[3]|abstract	new[3]|new	coref	3-3
2-12	151-152	?	_	_	_	_

#Text=How does H1N1 affect someone who is infected ?
3-1	153-156	How	_	_	_	_
3-2	157-161	does	_	_	_	_
3-3	162-166	H1N1	abstract	giv	coref	4-3
3-4	167-173	affect	_	_	_	_
3-5	174-181	someone	person[6]	new[6]	ana	13-22[92_6]
3-6	182-185	who	person[6]	new[6]	_	_
3-7	186-188	is	person[6]	new[6]	_	_
3-8	189-197	infected	person[6]	new[6]	_	_
3-9	198-199	?	_	_	_	_

#Text=Since the H1N1 pandemic virus is now the dominant influenza virus circulating worldwide , most cases of influenza-like illness are likely pandemic influenza .
4-1	200-205	Since	_	_	_	_
4-2	206-209	the	abstract[9]	new[9]	coref	4-7[11_9]
4-3	210-214	H1N1	abstract|abstract[9]	giv|new[9]	coref	7-3
4-4	215-223	pandemic	plant|abstract[9]	new|new[9]	coref	6-31
4-5	224-229	virus	abstract[9]	new[9]	_	_
4-6	230-232	is	_	_	_	_
4-7	233-236	now	abstract[11]	giv[11]	coref	7-1[40_11]
4-8	237-240	the	abstract[11]	giv[11]	_	_
4-9	241-249	dominant	abstract[11]	giv[11]	_	_
4-10	250-259	influenza	abstract|abstract[11]	new|giv[11]	_	_
4-11	260-265	virus	abstract[11]	giv[11]	_	_
4-12	266-277	circulating	abstract[11]	giv[11]	_	_
4-13	278-287	worldwide	abstract[11]	giv[11]	_	_
4-14	288-289	,	_	_	_	_
4-15	290-294	most	abstract[12]	new[12]	coref	4-21[14_12]
4-16	295-300	cases	abstract[12]	new[12]	_	_
4-17	301-303	of	abstract[12]	new[12]	_	_
4-18	304-318	influenza-like	abstract[12]|abstract[13]	new[12]|new[13]	coref	6-10[27_13]
4-19	319-326	illness	abstract[12]|abstract[13]	new[12]|new[13]	_	_
4-20	327-330	are	_	_	_	_
4-21	331-337	likely	abstract[14]	giv[14]	coref	6-31[37_14]
4-22	338-346	pandemic	abstract[14]	giv[14]	_	_
4-23	347-356	influenza	abstract[14]	giv[14]	_	_
4-24	357-358	.	_	_	_	_

#Text=Typical symptoms to watch for include fever , cough , headache , body aches , sore throat and runny nose .
5-1	359-366	Typical	abstract[15]	new[15]	coref	6-14[29_15]
5-2	367-375	symptoms	abstract[15]	new[15]	_	_
5-3	376-378	to	abstract[15]	new[15]	_	_
5-4	379-384	watch	abstract[15]	new[15]	_	_
5-5	385-388	for	abstract[15]	new[15]	_	_
5-6	389-396	include	_	_	_	_
5-7	397-402	fever	abstract	new	coref	15-7[111_0]
5-8	403-404	,	_	_	_	_
5-9	405-410	cough	abstract	new	coref	19-14
5-10	411-412	,	_	_	_	_
5-11	413-421	headache	abstract	new	coref	19-16
5-12	422-423	,	_	_	_	_
5-13	424-428	body	object|abstract[20]	new|new[20]	_	_
5-14	429-434	aches	abstract[20]	new[20]	_	_
5-15	435-436	,	_	_	_	_
5-16	437-441	sore	object[21]	new[21]	coref	19-23[142_21]
5-17	442-448	throat	object[21]	new[21]	_	_
5-18	449-452	and	_	_	_	_
5-19	453-458	runny	object[22]	new[22]	coref	19-26[143_22]
5-20	459-463	nose	object[22]	new[22]	_	_
5-21	464-465	.	_	_	_	_

#Text=WHO advises health care providers to treat people with influenza-like illness based on their symptoms and the progress of their illness , and not to wait for laboratory confirmation of pandemic influenza .
6-1	466-469	WHO	organization	giv	coref	8-11
6-2	470-477	advises	_	_	_	_
6-3	478-484	health	abstract[24]|person[25]	new[24]|new[25]	coref	21-6[151_24]
6-4	485-489	care	abstract[24]|person[25]	new[24]|new[25]	_	_
6-5	490-499	providers	person[25]	new[25]	_	_
6-6	500-502	to	_	_	_	_
6-7	503-508	treat	_	_	_	_
6-8	509-515	people	person[26]	new[26]	ana	6-14[0_26]
6-9	516-520	with	person[26]	new[26]	_	_
6-10	521-535	influenza-like	person[26]|abstract[27]	new[26]|giv[27]	coref	6-20[33_27]
6-11	536-543	illness	person[26]|abstract[27]	new[26]|giv[27]	_	_
6-12	544-549	based	_	_	_	_
6-13	550-552	on	_	_	_	_
6-14	553-558	their	person|abstract[29]|abstract[30]	giv|giv[29]|giv[30]	coref|ana|coref	6-14[30_29]|6-20|12-4[74_30]
6-15	559-567	symptoms	abstract[29]|abstract[30]	giv[29]|giv[30]	_	_
6-16	568-571	and	abstract[30]	giv[30]	_	_
6-17	572-575	the	abstract[30]|abstract[31]	giv[30]|new[31]	_	_
6-18	576-584	progress	abstract[30]|abstract[31]	giv[30]|new[31]	_	_
6-19	585-587	of	abstract[30]|abstract[31]	giv[30]|new[31]	_	_
6-20	588-593	their	abstract[30]|abstract[31]|person|abstract[33]	giv[30]|new[31]|giv|giv[33]	coref|coref	8-23[51_33]|14-1[103_0]
6-21	594-601	illness	abstract[30]|abstract[31]|abstract[33]	giv[30]|new[31]|giv[33]	_	_
6-22	602-603	,	_	_	_	_
6-23	604-607	and	_	_	_	_
6-24	608-611	not	_	_	_	_
6-25	612-614	to	_	_	_	_
6-26	615-619	wait	_	_	_	_
6-27	620-623	for	_	_	_	_
6-28	624-634	laboratory	place|event[35]	new|new[35]	coref	8-2
6-29	635-647	confirmation	event[35]	new[35]	_	_
6-30	648-650	of	event[35]	new[35]	_	_
6-31	651-659	pandemic	event[35]|plant|abstract[37]	new[35]|giv|giv[37]	coref|coref	7-2|8-5[0_37]
6-32	660-669	influenza	event[35]|abstract[37]	new[35]|giv[37]	_	_
6-33	670-671	.	_	_	_	_

#Text=The pandemic H1N1 virus has already spread worldwide .
7-1	672-675	The	abstract[40]	giv[40]	coref	8-30[53_40]
7-2	676-684	pandemic	plant|abstract[40]	giv|giv[40]	coref	12-13
7-3	685-689	H1N1	abstract|abstract[40]	giv|giv[40]	coref	9-24
7-4	690-695	virus	abstract[40]	giv[40]	_	_
7-5	696-699	has	_	_	_	_
7-6	700-707	already	_	_	_	_
7-7	708-714	spread	_	_	_	_
7-8	715-724	worldwide	_	_	_	_
7-9	725-726	.	_	_	_	_

#Text=Regarding laboratory testing of cases , public health authorities and WHO partners continue to do selective testing of samples from patients with influenza-like illness to characterize outbreaks , monitor the virus and identify disease trends .
8-1	727-736	Regarding	_	_	_	_
8-2	737-747	laboratory	place|abstract[42]	giv|new[42]	_	_
8-3	748-755	testing	abstract[42]	new[42]	_	_
8-4	756-758	of	abstract[42]	new[42]	_	_
8-5	759-764	cases	abstract[42]|abstract	new[42]|giv	coref	10-12
8-6	765-766	,	_	_	_	_
8-7	767-773	public	organization[45]	new[45]	_	_
8-8	774-780	health	abstract|organization[45]	new|new[45]	_	_
8-9	781-792	authorities	organization[45]	new[45]	_	_
8-10	793-796	and	_	_	_	_
8-11	797-800	WHO	organization|person[47]	giv|new[47]	coref	12-16
8-12	801-809	partners	person[47]	new[47]	_	_
8-13	810-818	continue	_	_	_	_
8-14	819-821	to	_	_	_	_
8-15	822-824	do	_	_	_	_
8-16	825-834	selective	abstract[48]	new[48]	_	_
8-17	835-842	testing	abstract[48]	new[48]	_	_
8-18	843-845	of	abstract[48]	new[48]	_	_
8-19	846-853	samples	abstract[48]|substance[49]	new[48]|new[49]	_	_
8-20	854-858	from	abstract[48]|substance[49]	new[48]|new[49]	_	_
8-21	859-867	patients	abstract[48]|substance[49]|person[50]	new[48]|new[49]|new[50]	coref	12-2[73_50]
8-22	868-872	with	abstract[48]|substance[49]|person[50]	new[48]|new[49]|new[50]	_	_
8-23	873-887	influenza-like	abstract[48]|substance[49]|person[50]|abstract[51]	new[48]|new[49]|new[50]|giv[51]	coref	12-6[75_51]
8-24	888-895	illness	abstract[48]|substance[49]|person[50]|abstract[51]	new[48]|new[49]|new[50]|giv[51]	_	_
8-25	896-898	to	_	_	_	_
8-26	899-911	characterize	_	_	_	_
8-27	912-921	outbreaks	event	new	_	_
8-28	922-923	,	_	_	_	_
8-29	924-931	monitor	_	_	_	_
8-30	932-935	the	abstract[53]	giv[53]	coref	11-15[0_53]
8-31	936-941	virus	abstract[53]	giv[53]	_	_
8-32	942-945	and	_	_	_	_
8-33	946-954	identify	_	_	_	_
8-34	955-962	disease	abstract|abstract[55]	new|new[55]	coref	13-7[86_0]
8-35	963-969	trends	abstract[55]	new[55]	_	_
8-36	970-971	.	_	_	_	_

#Text=Anti-viral drugs ( which are medicines that act directly on viruses to stop them from multiplying ) should not be taken to prevent H1N1 .
9-1	972-982	Anti-viral	substance[56]	new[56]	coref	10-3[61_56]
9-2	983-988	drugs	substance[56]	new[56]	_	_
9-3	989-990	(	substance[56]	new[56]	_	_
9-4	991-996	which	substance[56]|substance[57]	new[56]|new[57]	ana	9-14[0_57]
9-5	997-1000	are	substance[56]|substance[57]	new[56]|new[57]	_	_
9-6	1001-1010	medicines	substance[56]|substance[57]	new[56]|new[57]	_	_
9-7	1011-1015	that	substance[56]|substance[57]	new[56]|new[57]	_	_
9-8	1016-1019	act	substance[56]|substance[57]	new[56]|new[57]	_	_
9-9	1020-1028	directly	substance[56]|substance[57]	new[56]|new[57]	_	_
9-10	1029-1031	on	substance[56]|substance[57]	new[56]|new[57]	_	_
9-11	1032-1039	viruses	substance[56]|substance[57]|animal	new[56]|new[57]|new	coref	17-15[122_0]
9-12	1040-1042	to	_	_	_	_
9-13	1043-1047	stop	_	_	_	_
9-14	1048-1052	them	substance	giv	_	_
9-15	1053-1057	from	_	_	_	_
9-16	1058-1069	multiplying	_	_	_	_
9-17	1070-1071	)	_	_	_	_
9-18	1072-1078	should	_	_	_	_
9-19	1079-1082	not	_	_	_	_
9-20	1083-1085	be	_	_	_	_
9-21	1086-1091	taken	_	_	_	_
9-22	1092-1094	to	_	_	_	_
9-23	1095-1102	prevent	_	_	_	_
9-24	1103-1107	H1N1	abstract	giv	coref	16-3
9-25	1108-1109	.	_	_	_	_

#Text=There are two antiviral drugs are being used to treat pandemic influenza infections .
10-1	1110-1115	There	_	_	_	_
10-2	1116-1119	are	_	_	_	_
10-3	1120-1123	two	substance[61]	giv[61]	_	_
10-4	1124-1133	antiviral	substance[61]	giv[61]	_	_
10-5	1134-1139	drugs	substance[61]	giv[61]	_	_
10-6	1140-1143	are	substance[61]	giv[61]	_	_
10-7	1144-1149	being	substance[61]	giv[61]	_	_
10-8	1150-1154	used	substance[61]	giv[61]	_	_
10-9	1155-1157	to	substance[61]	giv[61]	_	_
10-10	1158-1163	treat	substance[61]	giv[61]	_	_
10-11	1164-1172	pandemic	substance[61]|plant[63]	giv[61]|new[63]	ana	11-1[0_63]
10-12	1173-1182	influenza	substance[61]|abstract|plant[63]	giv[61]|giv|new[63]	coref	11-14
10-13	1183-1193	infections	substance[61]|plant[63]	giv[61]|new[63]	_	_
10-14	1194-1195	.	_	_	_	_

#Text=These are oseltamivir and zanamivir , which both block the action of an influenza virus protein called neuraminidase .
11-1	1196-1201	These	plant	giv	coref	11-3
11-2	1202-1205	are	_	_	_	_
11-3	1206-1217	oseltamivir	plant|plant[66]	giv|giv[66]	coref|coref	11-3[66_0]|12-21[0_66]
11-4	1218-1221	and	plant[66]	giv[66]	_	_
11-5	1222-1231	zanamivir	plant[66]|plant[67]	giv[66]|new[67]	coref	13-36[0_67]
11-6	1232-1233	,	plant[66]|plant[67]	giv[66]|new[67]	_	_
11-7	1234-1239	which	plant[66]|plant[67]	giv[66]|new[67]	_	_
11-8	1240-1244	both	plant[66]|plant[67]	giv[66]|new[67]	_	_
11-9	1245-1250	block	plant[66]|plant[67]	giv[66]|new[67]	_	_
11-10	1251-1254	the	plant[66]|plant[67]|event[68]	giv[66]|new[67]|new[68]	_	_
11-11	1255-1261	action	plant[66]|plant[67]|event[68]	giv[66]|new[67]|new[68]	_	_
11-12	1262-1264	of	plant[66]|plant[67]|event[68]	giv[66]|new[67]|new[68]	_	_
11-13	1265-1267	an	plant[66]|plant[67]|event[68]|substance[71]	giv[66]|new[67]|new[68]|new[71]	_	_
11-14	1268-1277	influenza	plant[66]|plant[67]|event[68]|abstract|substance[71]	giv[66]|new[67]|new[68]|giv|new[71]	coref	12-13[77_0]
11-15	1278-1283	virus	plant[66]|plant[67]|event[68]|abstract|substance[71]	giv[66]|new[67]|new[68]|giv|new[71]	coref	17-1[117_0]
11-16	1284-1291	protein	plant[66]|plant[67]|event[68]|substance[71]	giv[66]|new[67]|new[68]|new[71]	_	_
11-17	1292-1298	called	plant[66]|plant[67]|event[68]|substance[71]	giv[66]|new[67]|new[68]|new[71]	_	_
11-18	1299-1312	neuraminidase	plant[66]|plant[67]|event[68]|substance[71]|abstract	giv[66]|new[67]|new[68]|new[71]|new	_	_
11-19	1313-1314	.	_	_	_	_

#Text=For patients with symptoms of severe illness that are probably due to pandemic influenza , WHO recommends that treatment with oseltamivir should start immediately , no matter when the illness started and without waiting for laboratory results to confirm infection .
12-1	1315-1318	For	_	_	_	_
12-2	1319-1327	patients	person[73]	giv[73]	coref	13-2[84_73]
12-3	1328-1332	with	person[73]	giv[73]	_	_
12-4	1333-1341	symptoms	person[73]|abstract[74]	giv[73]|giv[74]	coref	13-45[0_74]
12-5	1342-1344	of	person[73]|abstract[74]	giv[73]|giv[74]	_	_
12-6	1345-1351	severe	person[73]|abstract[74]|abstract[75]	giv[73]|giv[74]|giv[75]	coref	12-29[81_75]
12-7	1352-1359	illness	person[73]|abstract[74]|abstract[75]	giv[73]|giv[74]|giv[75]	_	_
12-8	1360-1364	that	person[73]|abstract[74]	giv[73]|giv[74]	_	_
12-9	1365-1368	are	person[73]|abstract[74]	giv[73]|giv[74]	_	_
12-10	1369-1377	probably	person[73]|abstract[74]	giv[73]|giv[74]	_	_
12-11	1378-1381	due	person[73]|abstract[74]	giv[73]|giv[74]	_	_
12-12	1382-1384	to	person[73]|abstract[74]	giv[73]|giv[74]	_	_
12-13	1385-1393	pandemic	person[73]|abstract[74]|plant|abstract[77]	giv[73]|giv[74]|giv|giv[77]	coref|coref	13-10|13-10[88_77]
12-14	1394-1403	influenza	person[73]|abstract[74]|abstract[77]	giv[73]|giv[74]|giv[77]	_	_
12-15	1404-1405	,	_	_	_	_
12-16	1406-1409	WHO	organization	giv	coref	13-29
12-17	1410-1420	recommends	_	_	_	_
12-18	1421-1425	that	_	_	_	_
12-19	1426-1435	treatment	event[79]	new[79]	coref	13-31[95_79]
12-20	1436-1440	with	event[79]	new[79]	_	_
12-21	1441-1452	oseltamivir	event[79]|plant	new[79]|giv	coref	13-33[96_0]
12-22	1453-1459	should	_	_	_	_
12-23	1460-1465	start	_	_	_	_
12-24	1466-1477	immediately	_	_	_	_
12-25	1478-1479	,	_	_	_	_
12-26	1480-1482	no	_	_	_	_
12-27	1483-1489	matter	_	_	_	_
12-28	1490-1494	when	_	_	_	_
12-29	1495-1498	the	abstract[81]	giv[81]	coref	20-9[148_81]
12-30	1499-1506	illness	abstract[81]	giv[81]	_	_
12-31	1507-1514	started	_	_	_	_
12-32	1515-1518	and	_	_	_	_
12-33	1519-1526	without	_	_	_	_
12-34	1527-1534	waiting	_	_	_	_
12-35	1535-1538	for	_	_	_	_
12-36	1539-1549	laboratory	abstract[82]	new[82]	coref	13-51[101_82]
12-37	1550-1557	results	abstract[82]	new[82]	_	_
12-38	1558-1560	to	_	_	_	_
12-39	1561-1568	confirm	_	_	_	_
12-40	1569-1578	infection	event	new	_	_
12-41	1579-1580	.	_	_	_	_

#Text=For patients at higher risk for serious disease from pandemic influenza , including pregnant women , children under age 5 and those with certain underlying medical conditions , WHO recommends treatment with either oseltamivir or zanamivir as soon as possible after the onset of symptoms , and without waiting for the results of laboratory tests .
13-1	1581-1584	For	_	_	_	_
13-2	1585-1593	patients	person[84]	giv[84]	coref	13-14[89_84]
13-3	1594-1596	at	person[84]	giv[84]	_	_
13-4	1597-1603	higher	person[84]|abstract[85]	giv[84]|new[85]	coref	14-10[0_85]
13-5	1604-1608	risk	person[84]|abstract[85]	giv[84]|new[85]	_	_
13-6	1609-1612	for	person[84]|abstract[85]	giv[84]|new[85]	_	_
13-7	1613-1620	serious	person[84]|abstract[85]|abstract[86]	giv[84]|new[85]|giv[86]	_	_
13-8	1621-1628	disease	person[84]|abstract[85]|abstract[86]	giv[84]|new[85]|giv[86]	_	_
13-9	1629-1633	from	person[84]|abstract[85]|abstract[86]	giv[84]|new[85]|giv[86]	_	_
13-10	1634-1642	pandemic	person[84]|abstract[85]|abstract[86]|plant|abstract[88]	giv[84]|new[85]|giv[86]|giv|giv[88]	coref	17-16[0_88]
13-11	1643-1652	influenza	person[84]|abstract[85]|abstract[86]|abstract[88]	giv[84]|new[85]|giv[86]|giv[88]	_	_
13-12	1653-1654	,	person[84]	giv[84]	_	_
13-13	1655-1664	including	person[84]	giv[84]	_	_
13-14	1665-1673	pregnant	person[84]|person[89]	giv[84]|giv[89]	_	_
13-15	1674-1679	women	person[84]|person[89]	giv[84]|giv[89]	_	_
13-16	1680-1681	,	person[84]	giv[84]	_	_
13-17	1682-1690	children	person[84]|person[90]	giv[84]|new[90]	_	_
13-18	1691-1696	under	person[84]|person[90]	giv[84]|new[90]	_	_
13-19	1697-1700	age	person[84]|person[90]|abstract[91]	giv[84]|new[90]|new[91]	_	_
13-20	1701-1702	5	person[84]|person[90]|abstract[91]	giv[84]|new[90]|new[91]	_	_
13-21	1703-1706	and	person[84]	giv[84]	_	_
13-22	1707-1712	those	person[84]|person[92]	giv[84]|giv[92]	coref	16-5[114_92]
13-23	1713-1717	with	person[84]|person[92]	giv[84]|giv[92]	_	_
13-24	1718-1725	certain	person[84]|person[92]|abstract[93]	giv[84]|giv[92]|new[93]	_	_
13-25	1726-1736	underlying	person[84]|person[92]|abstract[93]	giv[84]|giv[92]|new[93]	_	_
13-26	1737-1744	medical	person[84]|person[92]|abstract[93]	giv[84]|giv[92]|new[93]	_	_
13-27	1745-1755	conditions	person[84]|person[92]|abstract[93]	giv[84]|giv[92]|new[93]	_	_
13-28	1756-1757	,	_	_	_	_
13-29	1758-1761	WHO	organization	giv	_	_
13-30	1762-1772	recommends	_	_	_	_
13-31	1773-1782	treatment	event[95]	giv[95]	coref	20-15[0_95]
13-32	1783-1787	with	event[95]	giv[95]	_	_
13-33	1788-1794	either	event[95]|plant[96]|plant[97]	giv[95]|giv[96]|giv[97]	coref	13-33[97_96]
13-34	1795-1806	oseltamivir	event[95]|plant[96]|plant[97]	giv[95]|giv[96]|giv[97]	_	_
13-35	1807-1809	or	event[95]|plant[97]	giv[95]|giv[97]	_	_
13-36	1810-1819	zanamivir	event[95]|plant[97]|plant	giv[95]|giv[97]|giv	_	_
13-37	1820-1822	as	_	_	_	_
13-38	1823-1827	soon	_	_	_	_
13-39	1828-1830	as	_	_	_	_
13-40	1831-1839	possible	_	_	_	_
13-41	1840-1845	after	_	_	_	_
13-42	1846-1849	the	event[99]	new[99]	_	_
13-43	1850-1855	onset	event[99]	new[99]	_	_
13-44	1856-1858	of	event[99]	new[99]	_	_
13-45	1859-1867	symptoms	event[99]|abstract	new[99]|giv	coref	14-15[106_0]
13-46	1868-1869	,	_	_	_	_
13-47	1870-1873	and	_	_	_	_
13-48	1874-1881	without	_	_	_	_
13-49	1882-1889	waiting	_	_	_	_
13-50	1890-1893	for	_	_	_	_
13-51	1894-1897	the	abstract[101]	giv[101]	_	_
13-52	1898-1905	results	abstract[101]	giv[101]	_	_
13-53	1906-1908	of	abstract[101]	giv[101]	_	_
13-54	1909-1919	laboratory	abstract[101]|event[102]	giv[101]|new[102]	_	_
13-55	1920-1925	tests	abstract[101]|event[102]	giv[101]|new[102]	_	_
13-56	1926-1927	.	_	_	_	_

#Text=Otherwise healthy people who are not from a higher risk group but who have persistent or rapidly worsening symptoms should be treated with antivirals .
14-1	1928-1937	Otherwise	person[103]	giv[103]	coref	18-16[125_103]
14-2	1938-1945	healthy	person[103]	giv[103]	_	_
14-3	1946-1952	people	person[103]	giv[103]	_	_
14-4	1953-1956	who	person[103]|person[105]	giv[103]|new[105]	_	_
14-5	1957-1960	are	person[103]|person[105]	giv[103]|new[105]	_	_
14-6	1961-1964	not	person[103]|person[105]	giv[103]|new[105]	_	_
14-7	1965-1969	from	person[103]|person[105]	giv[103]|new[105]	_	_
14-8	1970-1971	a	person[103]|person[105]	giv[103]|new[105]	_	_
14-9	1972-1978	higher	person[103]|person[105]	giv[103]|new[105]	_	_
14-10	1979-1983	risk	person[103]|abstract|person[105]	giv[103]|giv|new[105]	_	_
14-11	1984-1989	group	person[103]|person[105]	giv[103]|new[105]	_	_
14-12	1990-1993	but	person[103]	giv[103]	_	_
14-13	1994-1997	who	person[103]	giv[103]	_	_
14-14	1998-2002	have	person[103]	giv[103]	_	_
14-15	2003-2013	persistent	person[103]|abstract[106]	giv[103]|giv[106]	coref	15-1[108_106]
14-16	2014-2016	or	person[103]|abstract[106]	giv[103]|giv[106]	_	_
14-17	2017-2024	rapidly	person[103]|abstract[106]	giv[103]|giv[106]	_	_
14-18	2025-2034	worsening	person[103]|abstract[106]	giv[103]|giv[106]	_	_
14-19	2035-2043	symptoms	person[103]|abstract[106]	giv[103]|giv[106]	_	_
14-20	2044-2050	should	_	_	_	_
14-21	2051-2053	be	_	_	_	_
14-22	2054-2061	treated	_	_	_	_
14-23	2062-2066	with	_	_	_	_
14-24	2067-2077	antivirals	substance	new	_	_
14-25	2078-2079	.	_	_	_	_

#Text=These symptoms include difficulty breathing or a high fever that lasts beyond three days .
15-1	2080-2085	These	abstract[108]	giv[108]	_	_
15-2	2086-2094	symptoms	abstract[108]	giv[108]	_	_
15-3	2095-2102	include	_	_	_	_
15-4	2103-2113	difficulty	abstract[109]	new[109]	coref	21-15[154_109]
15-5	2114-2123	breathing	abstract[109]|abstract	new[109]|new	coref	21-16
15-6	2124-2126	or	_	_	_	_
15-7	2127-2128	a	abstract[111]	giv[111]	coref	19-12[0_111]
15-8	2129-2133	high	abstract[111]	giv[111]	_	_
15-9	2134-2139	fever	abstract[111]	giv[111]	_	_
15-10	2140-2144	that	abstract[111]	giv[111]	_	_
15-11	2145-2150	lasts	abstract[111]	giv[111]	_	_
15-12	2151-2157	beyond	abstract[111]	giv[111]	_	_
15-13	2158-2163	three	abstract[111]|time[112]	giv[111]|new[112]	coref	21-29[158_112]
15-14	2164-2168	days	abstract[111]|time[112]	giv[111]|new[112]	_	_
15-15	2169-2170	.	_	_	_	_

#Text=How does H1N1 affect someone who is infected ?
16-1	2171-2174	How	_	_	_	_
16-2	2175-2179	does	_	_	_	_
16-3	2180-2184	H1N1	abstract	giv	coref	17-2
16-4	2185-2191	affect	_	_	_	_
16-5	2192-2199	someone	person[114]	giv[114]	_	_
16-6	2200-2203	who	person[114]	giv[114]	_	_
16-7	2204-2206	is	person[114]	giv[114]	_	_
16-8	2207-2215	infected	person[114]	giv[114]	_	_
16-9	2216-2217	?	_	_	_	_

#Text=Pandemic H1N1 virus is spread from person to person in the same way that seasonal influenza viruses are spread .
17-1	2218-2226	Pandemic	person|abstract[117]	new|giv[117]	coref	19-4
17-2	2227-2231	H1N1	abstract|abstract[117]	giv|giv[117]	_	_
17-3	2232-2237	virus	abstract[117]	giv[117]	_	_
17-4	2238-2240	is	_	_	_	_
17-5	2241-2247	spread	_	_	_	_
17-6	2248-2252	from	_	_	_	_
17-7	2253-2259	person	person	new	_	_
17-8	2260-2262	to	_	_	_	_
17-9	2263-2269	person	person	new	_	_
17-10	2270-2272	in	_	_	_	_
17-11	2273-2276	the	abstract[120]	new[120]	ana	18-1[0_120]
17-12	2277-2281	same	abstract[120]	new[120]	_	_
17-13	2282-2285	way	abstract[120]	new[120]	_	_
17-14	2286-2290	that	abstract[120]	new[120]	_	_
17-15	2291-2299	seasonal	abstract[120]|animal[122]	new[120]|giv[122]	_	_
17-16	2300-2309	influenza	abstract[120]|abstract|animal[122]	new[120]|giv|giv[122]	coref	18-7[124_0]
17-17	2310-2317	viruses	abstract[120]|animal[122]	new[120]|giv[122]	_	_
17-18	2318-2321	are	abstract[120]	new[120]	_	_
17-19	2322-2328	spread	abstract[120]	new[120]	_	_
17-20	2329-2330	.	_	_	_	_

#Text=It is transmitted as easily as the normal seasonal flu and can be passed to other people by exposure to infected droplets expelled by coughing or sneezing that can be inhaled , or that can contaminate hands or surfaces .
18-1	2331-2333	It	abstract	giv	_	_
18-2	2334-2336	is	_	_	_	_
18-3	2337-2348	transmitted	_	_	_	_
18-4	2349-2351	as	_	_	_	_
18-5	2352-2358	easily	_	_	_	_
18-6	2359-2361	as	_	_	_	_
18-7	2362-2365	the	abstract[124]	giv[124]	coref	19-3[134_124]
18-8	2366-2372	normal	abstract[124]	giv[124]	_	_
18-9	2373-2381	seasonal	abstract[124]	giv[124]	_	_
18-10	2382-2385	flu	abstract[124]	giv[124]	_	_
18-11	2386-2389	and	_	_	_	_
18-12	2390-2393	can	_	_	_	_
18-13	2394-2396	be	_	_	_	_
18-14	2397-2403	passed	_	_	_	_
18-15	2404-2406	to	_	_	_	_
18-16	2407-2412	other	person[125]	giv[125]	coref	20-1[145_125]
18-17	2413-2419	people	person[125]	giv[125]	_	_
18-18	2420-2422	by	_	_	_	_
18-19	2423-2431	exposure	abstract[126]	new[126]	_	_
18-20	2432-2434	to	abstract[126]	new[126]	_	_
18-21	2435-2443	infected	abstract[126]|substance[127]	new[126]|new[127]	_	_
18-22	2444-2452	droplets	abstract[126]|substance[127]	new[126]|new[127]	_	_
18-23	2453-2461	expelled	abstract[126]|substance[127]	new[126]|new[127]	_	_
18-24	2462-2464	by	abstract[126]|substance[127]	new[126]|new[127]	_	_
18-25	2465-2473	coughing	abstract[126]|substance[127]|event	new[126]|new[127]|new	_	_
18-26	2474-2476	or	abstract[126]|substance[127]	new[126]|new[127]	_	_
18-27	2477-2485	sneezing	abstract[126]|substance[127]|event	new[126]|new[127]|new	_	_
18-28	2486-2490	that	abstract[126]|substance[127]	new[126]|new[127]	_	_
18-29	2491-2494	can	abstract[126]|substance[127]	new[126]|new[127]	_	_
18-30	2495-2497	be	abstract[126]|substance[127]	new[126]|new[127]	_	_
18-31	2498-2505	inhaled	abstract[126]|substance[127]	new[126]|new[127]	_	_
18-32	2506-2507	,	abstract[126]|substance[127]	new[126]|new[127]	_	_
18-33	2508-2510	or	abstract[126]|substance[127]	new[126]|new[127]	_	_
18-34	2511-2515	that	abstract[126]|substance[127]	new[126]|new[127]	_	_
18-35	2516-2519	can	abstract[126]|substance[127]	new[126]|new[127]	_	_
18-36	2520-2531	contaminate	abstract[126]|substance[127]	new[126]|new[127]	_	_
18-37	2532-2537	hands	abstract[126]|substance[127]|object	new[126]|new[127]|new	_	_
18-38	2538-2540	or	abstract[126]|substance[127]	new[126]|new[127]	_	_
18-39	2541-2549	surfaces	abstract[126]|substance[127]|place	new[126]|new[127]|new	_	_
18-40	2550-2551	.	_	_	_	_

#Text=Signs of the pandemic influenza are flu-like , including malaise , fever , cough , headache , muscle and joint pain , sore throat and runny nose , and sometimes vomiting and diarrhoea .
19-1	2552-2557	Signs	abstract[132]	new[132]	_	_
19-2	2558-2560	of	abstract[132]	new[132]	_	_
19-3	2561-2564	the	abstract[132]|abstract[134]	new[132]|giv[134]	coref	20-6[147_134]
19-4	2565-2573	pandemic	abstract[132]|person|abstract[134]	new[132]|giv|giv[134]	coref	20-6
19-5	2574-2583	influenza	abstract[132]|abstract[134]	new[132]|giv[134]	_	_
19-6	2584-2587	are	_	_	_	_
19-7	2588-2596	flu-like	_	_	_	_
19-8	2597-2598	,	_	_	_	_
19-9	2599-2608	including	_	_	_	_
19-10	2609-2616	malaise	substance	new	_	_
19-11	2617-2618	,	_	_	_	_
19-12	2619-2624	fever	abstract	giv	coref	21-20[156_0]
19-13	2625-2626	,	_	_	_	_
19-14	2627-2632	cough	abstract	giv	_	_
19-15	2633-2634	,	_	_	_	_
19-16	2635-2643	headache	abstract	giv	_	_
19-17	2644-2645	,	_	_	_	_
19-18	2646-2652	muscle	object|abstract[141]	new|new[141]	_	_
19-19	2653-2656	and	abstract[141]	new[141]	_	_
19-20	2657-2662	joint	object|abstract[141]	new|new[141]	_	_
19-21	2663-2667	pain	abstract[141]	new[141]	_	_
19-22	2668-2669	,	_	_	_	_
19-23	2670-2674	sore	object[142]	giv[142]	_	_
19-24	2675-2681	throat	object[142]	giv[142]	_	_
19-25	2682-2685	and	_	_	_	_
19-26	2686-2691	runny	object[143]	giv[143]	_	_
19-27	2692-2696	nose	object[143]	giv[143]	_	_
19-28	2697-2698	,	_	_	_	_
19-29	2699-2702	and	_	_	_	_
19-30	2703-2712	sometimes	_	_	_	_
19-31	2713-2721	vomiting	_	_	_	_
19-32	2722-2725	and	_	_	_	_
19-33	2726-2735	diarrhoea	place	new	_	_
19-34	2736-2737	.	_	_	_	_

#Text=The majority of people with pandemic influenza experience mild illness and recover fully without treatment .
20-1	2738-2741	The	person[145]	giv[145]	coref	21-3[0_145]
20-2	2742-2750	majority	person[145]	giv[145]	_	_
20-3	2751-2753	of	person[145]	giv[145]	_	_
20-4	2754-2760	people	person[145]	giv[145]	_	_
20-5	2761-2765	with	person[145]	giv[145]	_	_
20-6	2766-2774	pandemic	person[145]|person|abstract[147]	giv[145]|giv|giv[147]	_	_
20-7	2775-2784	influenza	person[145]|abstract[147]	giv[145]|giv[147]	_	_
20-8	2785-2795	experience	_	_	_	_
20-9	2796-2800	mild	abstract[148]	giv[148]	_	_
20-10	2801-2808	illness	abstract[148]	giv[148]	_	_
20-11	2809-2812	and	_	_	_	_
20-12	2813-2820	recover	_	_	_	_
20-13	2821-2826	fully	_	_	_	_
20-14	2827-2834	without	_	_	_	_
20-15	2835-2844	treatment	event	giv	_	_
20-16	2845-2846	.	_	_	_	_

#Text=However , people should seek medical care if they experience shortness of breath or difficulty breathing , or if a fever , and especially high fever , continues more than three days .
21-1	2847-2854	However	_	_	_	_
21-2	2855-2856	,	_	_	_	_
21-3	2857-2863	people	person	giv	ana	21-9
21-4	2864-2870	should	_	_	_	_
21-5	2871-2875	seek	_	_	_	_
21-6	2876-2883	medical	abstract[151]	giv[151]	coref	22-12[161_151]
21-7	2884-2888	care	abstract[151]	giv[151]	_	_
21-8	2889-2891	if	_	_	_	_
21-9	2892-2896	they	person	giv	_	_
21-10	2897-2907	experience	_	_	_	_
21-11	2908-2917	shortness	_	_	_	_
21-12	2918-2920	of	_	_	_	_
21-13	2921-2927	breath	abstract	new	_	_
21-14	2928-2930	or	_	_	_	_
21-15	2931-2941	difficulty	abstract[154]	giv[154]	_	_
21-16	2942-2951	breathing	abstract[154]|abstract	giv[154]|giv	coref	22-18[163_0]
21-17	2952-2953	,	_	_	_	_
21-18	2954-2956	or	_	_	_	_
21-19	2957-2959	if	_	_	_	_
21-20	2960-2961	a	abstract[156]	giv[156]	coref	21-24[157_156]
21-21	2962-2967	fever	abstract[156]	giv[156]	_	_
21-22	2968-2969	,	_	_	_	_
21-23	2970-2973	and	_	_	_	_
21-24	2974-2984	especially	abstract[157]	giv[157]	coref	22-23[164_157]
21-25	2985-2989	high	abstract[157]	giv[157]	_	_
21-26	2990-2995	fever	abstract[157]	giv[157]	_	_
21-27	2996-2997	,	_	_	_	_
21-28	2998-3007	continues	_	_	_	_
21-29	3008-3012	more	time[158]	giv[158]	_	_
21-30	3013-3017	than	time[158]	giv[158]	_	_
21-31	3018-3023	three	time[158]	giv[158]	_	_
21-32	3024-3028	days	time[158]	giv[158]	_	_
21-33	3029-3030	.	_	_	_	_

#Text=For parents with a young child who is ill , seek medical care if a child has fast or labored breathing , continuing fever or convulsions ( seizures ) .
22-1	3031-3034	For	_	_	_	_
22-2	3035-3042	parents	person[159]	new[159]	_	_
22-3	3043-3047	with	person[159]	new[159]	_	_
22-4	3048-3049	a	person[159]|person[160]	new[159]|new[160]	coref	22-15[162_160]
22-5	3050-3055	young	person[159]|person[160]	new[159]|new[160]	_	_
22-6	3056-3061	child	person[159]|person[160]	new[159]|new[160]	_	_
22-7	3062-3065	who	person[159]|person[160]	new[159]|new[160]	_	_
22-8	3066-3068	is	person[159]|person[160]	new[159]|new[160]	_	_
22-9	3069-3072	ill	person[159]|person[160]	new[159]|new[160]	_	_
22-10	3073-3074	,	_	_	_	_
22-11	3075-3079	seek	_	_	_	_
22-12	3080-3087	medical	abstract[161]	giv[161]	_	_
22-13	3088-3092	care	abstract[161]	giv[161]	_	_
22-14	3093-3095	if	_	_	_	_
22-15	3096-3097	a	person[162]	giv[162]	_	_
22-16	3098-3103	child	person[162]	giv[162]	_	_
22-17	3104-3107	has	_	_	_	_
22-18	3108-3112	fast	abstract[163]	giv[163]	_	_
22-19	3113-3115	or	abstract[163]	giv[163]	_	_
22-20	3116-3123	labored	abstract[163]	giv[163]	_	_
22-21	3124-3133	breathing	abstract[163]	giv[163]	_	_
22-22	3134-3135	,	_	_	_	_
22-23	3136-3146	continuing	abstract[164]	giv[164]	_	_
22-24	3147-3152	fever	abstract[164]	giv[164]	_	_
22-25	3153-3155	or	_	_	_	_
22-26	3156-3167	convulsions	event	new	appos	22-28
22-27	3168-3169	(	_	_	_	_
22-28	3170-3178	seizures	event	giv	_	_
22-29	3179-3180	)	_	_	_	_
22-30	3181-3182	.	_	_	_	_
